| Authors: |
Ball BJ; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA, USA. brball@coh.org., Xiao W; Memorial Sloan Kettering Cancer Center, New York, NY, USA., Borthakur G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Nguyen LXT; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA, USA., Valerio M; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA, USA., Venkatachalam A; The Lautenberg Center for Immunology and Cancer Research, Institute of Medical Research Israel-Canada, Hebrew University-Hadassah Medical School, Jerusalem, Israel., Marcucci G; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA, USA., Stein AS; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA, USA., Thai DL; Edgewood Oncology, Brookline, MA, USA., Cook DN; Edgewood Oncology, Brookline, MA, USA., Chan K; BioTheryx, San Diego, CA, USA., Persaud S; Memorial Sloan Kettering Cancer Center, New York, NY, USA., Levine RL; Memorial Sloan Kettering Cancer Center, New York, NY, USA., Abdel-Wahab O; Memorial Sloan Kettering Cancer Center, New York, NY, USA., Ben-Neriah Y; The Lautenberg Center for Immunology and Cancer Research, Institute of Medical Research Israel-Canada, Hebrew University-Hadassah Medical School, Jerusalem, Israel., Stein EM; Memorial Sloan Kettering Cancer Center, New York, NY, USA. steine@mskcc.org. |
